PCI Pharma extends global clinical supply-chain services in Europe

By Akshay Kedari  Date: 2020-07-30

PCI Pharma extends global clinical supply-chain services in Europe

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin.

According to credible sources, the new COE facility is PCI Pharma’s efforts to extend its clinical supply-chain network in Europe, which would complement the existing services it provides in Ireland and UK.

The Berlin-based COE will cover a space of 17,000 square feet which will primarily focus on packaging, storing and distribution of pharmaceutical and biopharmaceutical therapies in Europe, sources claimed.

The facility is reportedly ideal to provide services to clinical trials eco-system in the region. It presently has around 38,100 active trial centers across Europe, of which France ranks first with 7,370 active trials followed by Germany, with around 4,418 trial centers.

VP and GM of Global Clinical Operations & Supply at PCI Pharma Services, Brian Keesee reportedly said that this expansion will enable the company to cater to the needs of European as well as global clients through the COE facility in Berlin. He further claimed that Berlin is an exceptional logistics center and will ensure minimum disruptions in the supply-chain amid Brexit.

Salim Haffar, CEO at PCI Pharma Services, also stated that the company’s strategy has always focused on increasing the capacity as well as the capabilities of its network of clinical trial services. He added that the recent acquisition of Bellwyck Pharma Services will enable PCI Pharma to improve its capabilities through the Berlin facility, in a bid to support the flourishing clinical trial sector in Europe.

Salim also confirmed that the recent investment will facilitate the company to offer clinical trial solutions of their advanced medicines to clients across the globe.

For those uninitiated, PCI Pharma is a major contributor to global healthcare industry since it offers drug development solutions that help in enhancing numerous medical products.

Source credits: https://www.businesswire.com/news/home/20200728005211/en/PCI-Pharma-Services-Announces-Global-Expansion-Clinical

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Facebook ad revenue could face more brunt over Apple’s privacy changes

Facebook ad revenue could face more brunt over Apple’s privacy changes

By Akshay Kedari

After Snap Inc. failed to reach its revenue targets last week, investors are now fearing that Facebook’s ad revenue could also be severely impacted due to Apple’s privacy changes. For those unaware, Apple’s privacy updates, which w...

Mark Zuckerberg planning to rebrand Facebook to reflect metaverse focus

Mark Zuckerberg planning to rebrand Facebook to reflect metaverse focus

By Akshay Kedari

There have been many businesses that have rebranded themselves to alter their identity with time. Following the league, social networking giant Facebook is also reportedly planning to rebrand the firm with a new name. On October 28, Chief Executive ...

Formula One teams to test second-generation biofuel during 2022 season

Formula One teams to test second-generation biofuel during 2022 season

By Akshay Kedari

The leading motorsport intends to achieve net-zero carbon status by the end of this decade. F1 has ruled out switching to an all-electric powertrain such as in Formula E. With increasing significance towards green mobility, Formula One teams are...

Apple’s iPhone 13 production may take a hit due to global chip shortage

Apple’s iPhone 13 production may take a hit due to global chip shortage

By Akshay Kedari

Apple Inc. is likely to cut down production of its iPhone 13 model by approximately 10 million units on account of the global chip shortage. The American multinational technology company was previously expected to manufacture 90 million units of the ...

Israel's GoTo Global acquires German e-moped sharing platform emmy

Israel's GoTo Global acquires German e-moped sharing platform emmy

By Akshay Kedari

Israel-based multimodal vehicle sharing services provider GoTo Global Mobility Ltd. has reportedly acquired Germany’s shared e-scooter company emmy. The acquisition will allow GoTo Global to enter the German market as well as accelerate its Eur...